• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need
 

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

on

  • 203 views

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need ...

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

3 Gastrointestinal Therapeutics in Asia-Pacific Market – Marketed Products (Global)
3.1 Irritable Bowel Syndrome
3.2 Ulcerative Colitis
3.3 Crohn’s Disease
3.4 Key Marketed Products
3.4.1 Amitiza
3.4.2 Humira
3.4.3 Remicade
3.4.4 Simponi
3.4.5 Cimzia
3.4.6 Tysabri

4 Gastrointestinal Therapeutics in Asia-Pacific Market – Pipeline Analysis
4.1 Irritable Bowel Syndrome
4.1.1 Overall Pipeline
4.1.2 Pipeline Analysis by Molecule Type
4.1.3 Pipeline Analysis by Mechanism of Action
4.2 Ulcerative Colitis Pipeline
4.2.1 Overall Pipeline
4.2.2 Pipeline Analysis by Molecule Type
4.2.3 Pipeline Analysis by Mechanism of Action
4.2.4 Crohn’s Disease Pipeline
4.2.5 Overall Pipeline
4.2.6 Pipeline Analysis by Molecule Type
4.2.7 Pipeline Analysis by Mechanism of Action
4.3 Promising Drug Candidates in the Pipeline
4.3.1 GSK-1605786
4.3.2 MLN0002
4.3.3 EMD-61753

View Full Report With Complete TOC at http://www.researchmoz.us/gastrointestinal-therapeutics-in-asia-pacific-markets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-need-report.html

Statistics

Views

Total Views
203
Views on SlideShare
203
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need Document Transcript

    • Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need ResearchMoz include new market research report" Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019: Industry Size, Shares, Growth, Trends And Forecast" to its huge collection of research reports. View Full Report - http://www.researchmoz.us/gastrointestinal-therapeutics-in-asia-pacificmarkets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-needreport.html Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Gastrointestinal Therapeutics in Asia-Pacific Market – Introduction 2.1 Irritable Bowel Syndrome 2.1.1 Classification 2.1.2 Symptoms 2.1.3 Etiology 2.1.4 Pathophysiology 2.1.5 Diagnosis 2.1.6 Epidemiology 2.1.7 Prognosis 2.1.8 Treatment Options 2.2 Ulcerative Colitis 2.2.1 Classification 2.2.2 Symptoms 2.2.3 Etiology 2.2.4 Pathophysiology 2.2.5 Diagnosis 2.2.6 Epidemiology
    • 2.2.7 Prognosis 2.2.8 Treatment Options 2.3 Crohn’s Disease 2.3.1 Classification 2.3.2 Symptoms 2.3.3 Etiology 2.3.4 Pathophysiology 2.3.5 Diagnosis 2.3.6 Epidemiology 2.3.7 Prognosis 2.3.8 Treatment Options 2.4 GBI Research Report Guidance 3 Gastrointestinal Therapeutics in Asia-Pacific Market – Marketed Products (Global) 3.1 Irritable Bowel Syndrome 3.2 Ulcerative Colitis 3.3 Crohn’s Disease 3.4 Key Marketed Products 3.4.1 Amitiza 3.4.2 Humira 3.4.3 Remicade 3.4.4 Simponi 3.4.5 Cimzia 3.4.6 Tysabri 4 Gastrointestinal Therapeutics in Asia-Pacific Market – Pipeline Analysis 4.1 Irritable Bowel Syndrome 4.1.1 Overall Pipeline 4.1.2 Pipeline Analysis by Molecule Type
    • 4.1.3 Pipeline Analysis by Mechanism of Action 4.2 Ulcerative Colitis Pipeline 4.2.1 Overall Pipeline 4.2.2 Pipeline Analysis by Molecule Type 4.2.3 Pipeline Analysis by Mechanism of Action 4.2.4 Crohn’s Disease Pipeline 4.2.5 Overall Pipeline 4.2.6 Pipeline Analysis by Molecule Type 4.2.7 Pipeline Analysis by Mechanism of Action 4.3 Promising Drug Candidates in the Pipeline 4.3.1 GSK-1605786 4.3.2 MLN0002 4.3.3 EMD-61753 5 Gastrointestinal Therapeutics in Asia-Pacific Market – Market Forecast to 2019 5.1 Asia-Pacific Markets 5.1.1 Treatment Usage Patterns 5.1.2 Annual Cost of Therapy 5.1.3 Market Size 5.2 Australia 5.2.1 Treatment Usage Patterns 5.2.2 Annual Cost of Therapy 5.2.3 Market Size 5.3 India 5.3.1 Treatment Usage Patterns 5.3.2 Annual Cost of Therapy 5.3.3 Market Size 5.4 China 5.4.1 Treatment Usage Patterns
    • 5.4.2 Annual Cost of Therapy 5.4.3 Market Size 5.5 Japan 5.5.1 Treatment Usage Patterns 5.5.2 Annual Cost of Therapy 5.5.3 Market Size 5.6 Drivers and Barriers 5.6.1 Drivers 5.6.2 Barriers 6 Gastrointestinal Therapeutics in Asia-Pacific Market – Deals and Strategic Consolidations (Global) 6.1 Deals Analysis 6.2 Major Co-Development Deals 6.2.1 AstraZeneca Enters into Co-Development Agreement with Ironwood Pharma for Linaclotide 6.2.2 Amgen Enters into Co-development Agreement with AstraZeneca for Five Monoclonal Antibodies 6.2.3 Galapagos and AbbVie Extend GLPG0634 Development Agreement to Include Crohn's Disease 6.3 Major Licensing Deals 6.3.1 AstraZeneca Enters into Licensing Agreement with Ardelyx for NHE3 Inhibitor Program 6.3.2 Sanofi-Aventis Enters into Licensing Agreement with Kyowa Hakko Kirin 6.3.3 GlaxoSmithKline Enters into Licensing Agreement with ChemoCentryx 7 Gastrointestinal Therapeutics in Asia-Pacific Market – Appendix 7.1 Market Definitions 7.2 Abbreviations 7.3 Sources 7.4 All Pipeline Drugs by Phase 7.4.1 Discovery 7.4.2 Preclinical
    • 7.4.3 IND/CTA-filed 7.4.4 Phase I 7.4.5 Phase II 7.4.6 Phase III 7.4.7 Pre-Registration 7.4.8 Undisclosed 7.5 Market Forecasts to 2019 7.5.1 Asia-Pacific Markets 7.5.2 Australia 7.5.3 India 7.5.4 China 7.5.5 Japan 7.6 Research Methodology 7.6.1 Coverage 7.6.2 Secondary Research 7.6.3 Primary Research 7.6.4 Therapeutic Landscape 7.6.5 Geographical Landscape 7.6.6 Pipeline Analysis 7.7 Expert Panel Validation 7.8 Contact Us 7.9 Disclaimer List of Tables Table 1: Gastrointestinal Therapeutics Market, Irritable Bowel Syndrome, Classification, 2009 Table 2: Gastrointestinal Therapeutics Market, Treatment Recommendations for Irritable Bowel Syndrome, 2009 Table 3: Gastrointestinal Therapeutics Market, Classification of Ulcerative Colitis, 2004 Table 4: Gastrointestinal Therapeutics Market, Diagnosis of Ulcerative Colitis, 2007
    • Table 5: Gastrointestinal Therapeutics Market, Difference Between Ulcerative Colitis and Crohn’s Disease, 2007 Table 6: Gastrointestinal Therapeutics Market, Treatment Options of Ulcerative Colitis, 2011 Table 7: Gastrointestinal Therapeutics Market, Classification of Crohn’s Disease, 2013 Table 8: Gastrointestinal Therapeutics Market, Percentage of Patients Affected by Symptoms of Crohn’s Disease (%), 2012 Table 9: Gastrointestinal Therapeutics Market, Treatment Options for Crohn’s Disease, 2009 Table 10: Gastrointestinal Therapeutics Market, Global, Pipeline (Discovery), 2013 Table 11: Gastrointestinal Therapeutics Market, Global, Pipeline (Preclinical), 2013 Table 12: Gastrointestinal Therapeutics Market, Global, Pipeline (IND/CTA-filed), 2013 Table 13: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase I), 2013 Table 14: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase II), 2013 Table 15: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase III), 2013 Table 16: Gastrointestinal Therapeutics Market, Global, Pipeline (Pre-Registration), 2013 Table 17: Gastrointestinal Therapeutics Market, Global, Pipeline (Undisclosed), 2012 Table 18: Gastrointestinal Therapeutics Asia-Pacific Markets, Irritable Bowel Syndrome, Market Forecast, 2012–2019 Table 19: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Ulcerative Colitis, Market Forecast, 2012–2019 Table 20: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Crohn’s Disease, Market Forecast, 2012–2019 Table 21: Gastrointestinal Therapeutics Market, Australia, Irritable Bowel Syndrome, Market Forecast, 2012–2019 Table 22: Gastrointestinal Therapeutics Market, Australia, Ulcerative Colitis, Market Forecast, 2012–2019 Table 23: Gastrointestinal Therapeutics Market, Australia, Crohn’s Disease, Market Forecast, 2012–2019 Table 24: Gastrointestinal Therapeutics Market, India, Irritable Bowel Syndrome, Market Forecast, 2012– 2019 Table 25: Gastrointestinal Therapeutics Market, India, Ulcerative Colitis, Market Forecast, 2012–2019 Table 26: Gastrointestinal Therapeutics Market, India, Crohn’s Disease, Market Forecast, 2012–2019 Table 27: Gastrointestinal Therapeutics Market, China, Irritable Bowel Syndrome, Market Forecast, 2012– 2019 Table 28: Gastrointestinal Therapeutics Market, China, Ulcerative Colitis, Market Forecast, 2012–2019
    • Table 29: Gastrointestinal Therapeutics Market, China, Crohn’s Disease, Market Forecast, 2012–2019 Table 30: Gastrointestinal Therapeutics Market, Japan, Irritable Bowel Syndrome, Market Forecast, 2012–2019 Table 31: Gastrointestinal Therapeutics Market, Japan, Ulcerative Colitis, Market Forecast, 2012–2019 Table 32: Gastrointestinal Therapeutics Market, Japan, Crohn’s Disease, Market Forecast, 2012–2019 List of Figures Figure 1: Gastrointestinal Therapeutics Market, Treatment Algorithm of Ulcerative Colitis, 2007 Figure 2: Gastrointestinal Therapeutics Market, Global, Sales of Amitiza ($m), 2006–2012 Figure 3: Gastrointestinal Therapeutics Market, Global, Sales of Humira ($bn), 2006–2012 Figure 4: Gastrointestinal Therapeutics Market, Global, Sales of Remicade ($bn), 2006–2012 Figure 5: Gastrointestinal Therapeutics Market, Global, Sales of Simponi ($m), 2009–2012 Figure 6: Gastrointestinal Therapeutics Market, Global, Sales of Cimzia ($m), 2008–2012 Figure 7: Gastrointestinal Therapeutics Market, Global, Sales of Tysabri ($m), 2006–2012 Figure 8: Gastrointestinal Therapeutics Market, Global, Irritable Bowel Syndrome, Pipeline, (%), 2013 Figure 9: Gastrointestinal Therapeutics Market, Global, Irritable Bowel Syndrome, Pipeline by Molecule Type, 2013 Figure 10: Gastrointestinal Therapeutics Market, Global, Irritable Bowel Syndrome, Pipeline by Mechanism of Action, 2012 Figure 11: Gastrointestinal Therapeutics Market, Global, Ulcerative Colitis, Pipeline, (%) 2013 Figure 12: Gastrointestinal Therapeutics Market, Global, Ulcerative Colitis, Pipeline by Molecule Type, 2013 Figure 13: Gastrointestinal Therapeutics Market, Global, Ulcerative Colitis, Pipeline by Mechanism of Action, 2013 Figure 14: Gastrointestinal Therapeutics Market, Global, Crohn’s Disease, Pipeline, (%), 2013 Figure 15: Gastrointestinal Therapeutics Market, Global, Crohn’s Disease, Pipeline by Molecule Type, 2013 Figure 16: Gastrointestinal Therapeutics Market, Global, Crohn’s Disease, Pipeline by Mechanism of Action, 2013 Figure 17: Gastrointestinal Therapeutics Market, Asia-Pacific, Market Size, 2012–2019 Figure 18: Gastrointestinal Therapeutics Market, Australia, Market Size, 2012–2019 Figure 19: Gastrointestinal Therapeutics Market, India, Market Size, 2012–2019
    • Figure 20: Gastrointestinal Therapeutics Market, China, Market Size, 2012–2019 Figure 21: Gastrointestinal Therapeutics Market, Japan, Market Size, 2012–2019 Figure 22: Gastrointestinal Therapeutics Market, Global, Deals, 2006–2013 Figure 23: Gastrointestinal Therapeutics Market, Global, Co-Development Deals, 2006–2013 Figure 24: Gastrointestinal Therapeutics Market, Global, Licensing Deals, 2006–2013 Figure 25: GBI Research Market Forecasting Model View Full Report - http://www.researchmoz.us/gastrointestinal-therapeutics-in-asia-pacificmarkets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-needreport.html About ResearchMoz ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. For More Information Kindly Contact: Website@ http://www.researchmoz.us/ Email: sales@researchmoz.us Browse Blog - http://latestmarketstudy.blogspot.com/ Visit: http://businessfuturetrends.blogspot.com/ Browse Blog - http://pramoddige91.wordpress.com/